Search results for "PPARa"

showing 10 items of 1343 documents

Challenges in the pharmacological treatment of geriatric asthma

2016

ABSTRACTAsthma in older populations is characterized by frequent comorbid conditions, which increase the risk of side effects and of detrimental interactions between respiratory and non-respiratory drugs. These observations lead to the need to manage asthma in older populations by applying a multidimensional assessment and a multidisciplinary treatment; therefore, we favor the use of the ‘geriatric’ term to define asthma in the elderly. Geriatric asthma is a complex disease, which may not necessarily imply that it is also complicated, although the two conditions may often coexist. On this basis, the switch from an organ-driven management to the holistic approach may be the key factor to att…

Agingmedicine.medical_specialtyComplex diseaseComorbidityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAnti-asthmatic AgentPharmacological treatmentOlder population03 medical and health sciences0302 clinical medicineMultidisciplinary approachAnimalsHumansMedicinePharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicinePsychiatryAgedAsthmabusiness.industryAge FactorsGeneral Medicinemedicine.diseaseComorbidityAsthmaInhaled treatment030228 respiratory systemAdherencePharmacology Toxicology and Pharmaceutics (all)businessExpert Review of Clinical Pharmacology
researchProduct

Comorbidities of Lung Disease in the Elderly

2017

Comorbidities are common in elderly individuals with chronic respiratory diseases. They can affect disease manifestations and severity and can even impact management. Comorbidities can affect the treatment of the lung disease, particularly because of the interaction with the respiratory drugs. Thus, a multidimensional approach with multidisciplinary intervention is suggested for elderly respiratory patients, switching from a disease-oriented scheme to a dysfunction-oriented approach. Unfortunately, older individuals are often excluded from clinical trials because of advanced age and comorbidities. This article reviews the role of comorbidities in the management of respiratory diseases in th…

Agingmedicine.medical_specialtyRespiratory Tract DiseasesComorbidityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)03 medical and health sciences0302 clinical medicineIntervention (counseling)medicineHumansSenile lung030212 general & internal medicineRespiratory systemIdiopathic lung fibrosiIntensive care medicineRespiratory Tract DiseaseAgedAsthmabusiness.industryChronic obstructive pulmonary diseasefood and beveragesmedicine.diseaseComorbidityAsthmaPatient Care ManagementClinical trial030228 respiratory systemLung diseaseGeriatrics and GerontologybusinessHumanClinics in Geriatric Medicine
researchProduct

Cardiac Micro–Computed Tomography Imaging of the Aging Coronary Vasculature

2012

Background— Alterations at the level of the coronary circulation with aging may play an important role in the evolution of age-associated changes in left ventricular (LV) fibrosis and function. However these age-associated changes in the coronary vasculature remain poorly defined primarily due to the lack of high resolution imaging technologies. The current study was designed to utilize cardiac micro–computed tomography (micro-CT) technology as a novel imaging strategy, to define the 3-dimensional coronary circulation in the young and aged heart and its relationship to LV fibrosis and function. Methods and Results— Young (2 months old; n=10) and aged (20 months old; n=10) Fischer rats unde…

Agingmedicine.medical_specialtyX-ray microtomographyBlood PressureArticleVentricular Dysfunction LeftCoronary circulationImaging Three-DimensionalFibrosisCoronary CirculationInternal medicineLv dysfunctionAnimalsMedicineRadiology Nuclear Medicine and imagingbusiness.industryMicro computed tomographyCoronary vasculatureImaging studyX-Ray Microtomographymedicine.diseaseFibrosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareRats Inbred F344Ratsmedicine.anatomical_structureBlood pressureEchocardiographyHigh resolution imaging techinques.Linear ModelsCardiologyCardiology and Cardiovascular MedicinebusinessCirculation: Cardiovascular Imaging
researchProduct

Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol

2015

Abstract Long-acting β 2 -adrenoceptor agonists, formoterol and salmeterol, represent a milestone in the treatments of chronic obstructive lung diseases. Although no specific indications concerning the choice of one molecule rather than another are provided by asthma and COPD guidelines, they present different pharmacological properties resulting in distinct clinical employment possibilities. In particular, salmeterol has a low intrinsic efficacy working as a partial receptor agonist, while formoterol is a full agonist with high intrinsic efficacy. From a clinical perspective, in the presence of low β 2 -adrenoceptors availability, like in inflamed airways, a full agonist can maintain its b…

AgonistChronic ObstructiveIntrinsic activitymedicine.drug_classSocio-culturaleLABASettore MED/10 - Malattie Dell'Apparato RespiratorioPharmacologyPartial agonistPulmonary DiseaseAsthma; Chronic obstructive pulmonary disease; Formoterol; LABA; Salmeterol; Internal MedicinePulmonary Disease Chronic Obstructiveimmune system diseasesFormoterol FumarateInternal MedicinemedicineHumansFormoterolSalmeterolSalmeterol XinafoateBronchodilator AgentAsthmaCOPDbusiness.industryChronic obstructive pulmonary diseaseMedicine (all)Asthma; Chronic obstructive pulmonary disease; Formoterol; LABA; Salmeterolrespiratory systemmedicine.diseaseAsthmaBronchodilator Agentsrespiratory tract diseasesTreatment OutcomeAnesthesiaFormoterolOnset of actionSalmeterolbusinessAsthma; Chronic obstructive pulmonary disease; Formoterol; LABA; Salmeterol; Bronchodilator Agents; Formoterol Fumarate; Humans; Pulmonary Disease Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome; Internal MedicineHumanmedicine.drugEuropean Journal of Internal Medicine
researchProduct

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

2014

Nicola Scichilone,1 Alida Benfante,1 Luca Morandi,2 Federico Bellini,2 Alberto Papi21Biomedical Department of Internal and Specialist Medicine, Section of Pulmonology, University of Palermo, Italy; 2Respiratory Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, ItalyAbstract: Asthma and chronic obstructive pulmonary disease (COPD) are among the most common chronic diseases worldwide, characterized by a condition of variable degree of airway obstruction and chronic airway inflammation. A large body of evidence has demonstrated the importance of small airways as a pharmacological target in these clinical conditions. Despite a deeper understanding of the pathophysiologic…

Agonistmedicine.medical_specialtymedicine.drug_classReviewPharmacologySettore MED/10 - Malattie Dell'Apparato RespiratorioInternal medicineinhalational therapymedicineCOPDRespiratory systemAsthmaCOPDlcsh:R5-920small airwaysCOPD asthma inhalational therapy small airwaysLungbusiness.industryrespiratory systemAirway obstructionasthmamedicine.diseasePathophysiologyrespiratory tract diseasesmedicine.anatomical_structureFormoterolbusinesslcsh:Medicine (General)medicine.drug
researchProduct

Mild bronchial epithelial damage after endurance exercise in humans

2008

Airway cells endurance exercise healthy subjectsSettore MED/10 - Malattie Dell'Apparato RespiratorioSettore BIO/09 - Fisiologia
researchProduct

Time course of changes in bronchial reactivity during early training in healthy subjects

2008

Airway response methacoline training time courseSettore MED/10 - Malattie Dell'Apparato RespiratorioSettore BIO/09 - Fisiologia
researchProduct

Airway Wall Thickness By HRCT Does Not Affect Airway Distensibility In Asthma And COPD

2013

Airways HRCT ASTHMA COPDSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Flow cytometric analysis of concanavalin A binding to isolated Golgi fractions from rat liver.

1993

Flow cytometry (FCM) has been used repeatedly to study lectin binding to whole cells. However, there are very few attempts to analyze glycoconjugates in isolated subcellular organelles. We have applied FCM to quantitate the specific binding of fluorescein-conjugated concanavalin A (FITC-Con A) to isolated cis and trans fractions of rat liver Golgi complex, the cell compartment involved in glycoprotein maturation and sorting. Our results show similar intensities of Con A-specific binding in the two fractions. Using this method we show a decreased FITC-Con A binding to both Golgi fractions in ethanol-treated rats, which is consistent to previous work on alcoholic effects on galactosyltransfer…

Alcohol DrinkingGlycoconjugateGolgi ApparatusCell FractionationFlow cytometrysymbols.namesakeOrganellemedicineConcanavalin AAnimalsRats Wistarchemistry.chemical_classificationGalactosyltransferaseBinding Sitesbiologymedicine.diagnostic_testLectinCell BiologyIntracellular MembranesGolgi apparatusFlow CytometryGalactosyltransferasesRatsDisease Models AnimalBiochemistrychemistryLiverConcanavalin Abiology.proteinsymbolsGlycoproteinFluorescein-5-isothiocyanateExperimental cell research
researchProduct

Nanochlorum eucaryotum — a green enigmatic alga: morphology, biochemistry and molecular biology

1994

In search of a natural systematic locality for algae — and also for other organisms — quite regularly the central question of evolution comes up. This proves as especially pertinent, when the taxonomic position of the most original phytoflagellates has to be considered. In the classical view of the direct filiation theory the ancestral phytoflagellata is positioned at the verge of the prokaryotic to the eukaryotic stage.

AlgaeEvolutionary biologyZoologyMorphology (biology)BiologyNanochlorum eucaryotumbiology.organism_classificationMitotic apparatus
researchProduct